U.S. regulations are too cautious. Europe has adopted a more sensible approach.

AEI's Scott Gottlieb argues that the focus of legislation should not be on creating employment benefits specifically targeted to H1N1, but instead on ways to mitigate risks in future pandemics by providing Americans with early vaccinations.

Consumers have been in the doldrums throughout this weak recovery, but the mood has gone from sour to despairing in recent months. The numbers have been so bad that the relatively obscure "Index of Consumer Sentiment" constructed by the University of Michigan has begun to receive the attention of political handicappers.

If the swine flu virus should continue to spread, or the infections worsen, rapid development of a vaccine could be our best protection.

The United States can avoid national security threats by being better prepared for pandemic flu.

A little fear goes a long way in fighting a pandemic.

Ernst R. Berndt and Anjli C. Warner discuss their new book, U.S. Markets for Vaccines: Characteristics, Case Studies, and Controversies.

Too much money is devoted to issues that seem well beyond the scope of a World Health Organization primarily concerned with infectious diseases.